+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Chronic Obstructive Pulmonary Disease Market and Competitive Landscape - 2020

  • ID: 5023472
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Chronic Obstructive Pulmonary Disease Market and Competitive Landscape - 2020, provides comprehensive insights into the Chronic Obstructive Pulmonary Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Chronic Obstructive Pulmonary Disease market size and drug sales. It also provides insights into Chronic Obstructive Pulmonary Disease epidemiology and late stage pipeline.

This research covers the following: Chronic Obstructive Pulmonary Disease treatment options, Chronic Obstructive Pulmonary Disease late stage clinical trials pipeline, Chronic Obstructive Pulmonary Disease prevalence by countries, Chronic Obstructive Pulmonary Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Chronic Obstructive Pulmonary Disease pipeline: Find out drugs in clinical trials for the treatment of Chronic Obstructive Pulmonary Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Chronic Obstructive Pulmonary Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Chronic Obstructive Pulmonary Disease by countries
  • Chronic Obstructive Pulmonary Disease drugs: Identify key drugs marketed and prescribed for Chronic Obstructive Pulmonary Disease in the US, including trade name, molecule name, and company
  • Chronic Obstructive Pulmonary Disease drugs sales: Find out the sales value for Chronic Obstructive Pulmonary Disease drugs by countries
  • Chronic Obstructive Pulmonary Disease market valuations: Find out the market size for Chronic Obstructive Pulmonary Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Chronic Obstructive Pulmonary Disease drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Chronic Obstructive Pulmonary Disease drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Chronic Obstructive Pulmonary Disease market
  • Develop in-depth knowledge of competition and markets
  • Analyze Chronic Obstructive Pulmonary Disease drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Chronic Obstructive Pulmonary Disease market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Chronic Obstructive Pulmonary Disease Treatment Options

2. Chronic Obstructive Pulmonary Disease Pipeline Insights
2.1. Chronic Obstructive Pulmonary Disease Phase 3 Clinical Trials
2.2. Chronic Obstructive Pulmonary Disease Phase 2 Clinical Trials
2.3. Chronic Obstructive Pulmonary Disease Phase 1 Clinical Trials

3. Chronic Obstructive Pulmonary Disease Epidemiology Analysis by Countries

4. Germany Chronic Obstructive Pulmonary Disease Market Insights
4.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in Germany
4.2. Germany Chronic Obstructive Pulmonary Disease Market Size & Forecast
4.3. Germany Chronic Obstructive Pulmonary Disease Drugs Sales Forecast
4.4. Germany Chronic Obstructive Pulmonary Disease Market Share Analysis

5. France Chronic Obstructive Pulmonary Disease Market Insights
5.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in France
5.2. France Chronic Obstructive Pulmonary Disease Market Size & Forecast
5.3. France Chronic Obstructive Pulmonary Disease Product Sales Forecast
5.4. France Chronic Obstructive Pulmonary Disease Market Share Analysis

6. Italy Chronic Obstructive Pulmonary Disease Market Insights
6.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in Italy
6.2. Italy Chronic Obstructive Pulmonary Disease Market Size & Forecast
6.3. Italy Chronic Obstructive Pulmonary Disease Product Sales Forecast
6.4. Italy Chronic Obstructive Pulmonary Disease Market Share Analysis

7. Spain Chronic Obstructive Pulmonary Disease Market Insights
7.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in Spain
7.2. Spain Chronic Obstructive Pulmonary Disease Market Size & Forecast
7.3. Spain Chronic Obstructive Pulmonary Disease Product Sales Forecast
7.4. Spain Chronic Obstructive Pulmonary Disease Market Share Analysis

8. UK Chronic Obstructive Pulmonary Disease Market Insights
8.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in UK
8.2. UK Chronic Obstructive Pulmonary Disease Market Size & Forecast
8.3. UK Chronic Obstructive Pulmonary Disease Product Sales Forecast
8.4. UK Chronic Obstructive Pulmonary Disease Market Share Analysis

9. Europe Chronic Obstructive Pulmonary Disease Market Insights
9.1. Europe Chronic Obstructive Pulmonary Disease Market Size & Forecast
9.2. Europe Chronic Obstructive Pulmonary Disease Product Sales Forecast
9.3. Europe Chronic Obstructive Pulmonary Disease Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Chronic Obstructive Pulmonary Disease Phase 3 Clinical Trials, Global, 2020
Table 2: Chronic Obstructive Pulmonary Disease Phase 2 Clinical Trials, Global, 2020
Table 3: Chronic Obstructive Pulmonary Disease Phase 1 Clinical Trials, Global, 2020
Table 4: Chronic Obstructive Pulmonary Disease Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Chronic Obstructive Pulmonary Disease in Germany, 2019
Table 6: Germany Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 8: Germany Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Chronic Obstructive Pulmonary Disease in France, 2019
Table 10: France Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 12: France Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Chronic Obstructive Pulmonary Disease in Italy, 2019
Table 14: Italy Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 16: Italy Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Chronic Obstructive Pulmonary Disease in Spain, 2019
Table 18: Spain Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 20: Spain Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Chronic Obstructive Pulmonary Disease in UK, 2019
Table 22: UK Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 24: UK Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 25: Europe Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Chronic Obstructive Pulmonary Disease Pipeline by Phase (%), Global, 2020
Figure 2: Chronic Obstructive Pulmonary Disease Prevalence by Countries, 2016 - 2024
Figure 3: Germany Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 4: Germany Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 5: Germany Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 6: Germany Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 7: France Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 8: France Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 9: France Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 10: France Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 11: Italy Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 12: Italy Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 13: Italy Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 14: Italy Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 15: Spain Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 16: Spain Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 17: Spain Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 18: Spain Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 19: UK Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 20: UK Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 21: UK Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 22: UK Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 23: Europe Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 24: Europe Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 25: Europe Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 26: Europe Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll